Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1)

Takehiko Yoshimitsu, Han W. Tun

Research output: Contribution to journalArticlepeer-review


Agelastatins are a family of tetracyclic alkaloids isolated from marine sponges. The patent examined in this publication covers the chemical synthesis of agelastatins A to F and eight analogues and their therapeutic use against hematologic malignancies. The claim on the chemical synthesis features a novel biomimetic cyclization of a tricyclic precursor, which streamlines scalable access to agelastatins and their analogues. This new synthetic approach can potentially expedite the research on these compounds for therapeutic use against cancers by making them more easily available. The claim on the therapeutic use against hematologic malignancies is based on the in vitro cytotoxicity against a limited number of cell lines and can be further strengthened by in vivo therapeutic evaluations focusing on specific hematologic malignancies. The comparative evaluation of the cytotoxicities of the natural alkaloids described in the application greatly enhances the understanding of their structure-activity relationships (SARs) relevant to the development of novel medicinal leads. Overall, the patent application is strong and has the potential to advance the rapidly expanding agelastatin research.

Original languageEnglish (US)
Pages (from-to)113-119
Number of pages7
JournalExpert Opinion on Therapeutic Patents
Issue number2
StatePublished - Feb 1 2017


  • Agelastatin alkaloid
  • apoptosis
  • blood cancer
  • chemical synthesis
  • cytotoxicity

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1)'. Together they form a unique fingerprint.

Cite this